AVE 33.3% 0.2¢ avecho biotechnology limited

esra ogru background, page-53

  1. 5,794 Posts.
    lightbulb Created with Sketch. 735
    As much as I hate saying this the SP is irrelevant for the short term unless you need to sell, want to sell or want to buy.
    Speculation and events will cause some retail investors to play safe and bail. How many will determine how low we go as the same situation makes new buyers wary.
    I'd take this over failure of trial results, because when the dust finally settles we still have a robust clinical trial and pipeline plan ahead.

    This reaction is inevitable but since a week ago, about 10 million shares traded?? Not massive.
    I look for movement in the top 20 holders.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.